Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
The blood test market worldwide is today around $75-80 billion
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
India's strategy against Covid was more effective than any other countries in the world
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Subscribe To Our Newsletter & Stay Updated